Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells

Nanotoxicology

Volumn 9, Issue S1, 2015, Pages 25-32

  Guadagnini, Rina ^a   Moreau, Kevin ^a   Hussain, Salik ^a,b   Marano, Francelyne ^a   Boland, Sonja ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Nanomedicine; Nanotoxicology; Oxidative stress; Pro inflammatory response; Pulmonary toxicity

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; OLEATE SODIUM; POLYGLACTIN; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; RIBOSOMAL PROTEIN L19; RIBOSOME PROTEIN; SILICA NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; AUTACOID; NANOPARTICLE;

ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS EPITHELIUM CELL; NANOTOXICOLOGY; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WST-1 ASSAY; ZETA POTENTIAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; LUNG; METABOLISM; PROCEDURES; TOXICITY TESTING;

CELL SURVIVAL; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; LUNG; NANOPARTICLES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TOXICITY TESTS;

EID: 84930003770     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.855830     Document Type: Article

References (27)

1. Acharya S, Sahoo SK. 2011. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170-83.
2. Allhoff F. 2009. The coming era of nanomedicine. Am J Bioeth 9:3-11.
3. Baeza-Squiban A, Boland S, Hussain S, Marano F. 2011. Health effects of nanoparticles. New York: Wiley.
4. Boland S, Baeza-Squiban A, Bonvallot V, Houcine O, Pain C, Meyer M, Marano F. 2001. Similar cellular effects induced by diesel exhaust particles from a representative diesel vehicle recovered from filters and Standard Reference Material 1650. Toxicol In Vitro 15:379-85.
5. Boland S, Guadagnini R, Baeza-Squiban A, Hussain S, Marano F. 2011. Nanoparticles used in medical applications for the lung: hopes for nanomedicine and fears for nanotoxicity. J Phys Conf Ser 304:012031. doi:10.1088/1742-6596/304/1/012031.
6. Correia Carreira S, Walker L, Paul K, Saunders M. 2015. The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placentalcell barrier model used within Nanotest. Nanotoxicology 9(S1):66-78.
7. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, et al. 2007. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050-5.
8. George I, Vranic S, Boland S, Borot M-C, Marano F, Baeza-Squiban A. 2013. Translocation of SiO2-NPs across in vitro human bronchial epithelial monolayer. J Phy Conf Ser 429:012022. doi:10.1088/1742-6596/429/1/012022.
9. Guadagnini R, Halamoda B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):25-32.
10. Halamoda Kenzaoui B, Chapuis Bernasconi C, Juillerat-Jeanneret L. 2013. Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles. Cell Biol Toxicol 29:39-58.
11. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, et al. 2009. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology 260:142-9.
12. Hussain S, Thomassen LC, Ferecatu I, Borot MC, Andreau K, Martens JA, et al. 2010. Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol 7:10. doi: 10.1186/1743-8977-7-10.
13. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, et al. 2011. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37:299-309.
14. Mahmoudi M, Laurent S, Shokrgozar MA, Hosseinkhani M. 2011a. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell ''vision'' versus physicochemical properties of nanoparticles. ACS Nano 5:7263-76.
15. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. 2011b. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev 63:24-46.
16. Mura S, Hillaireau H, Nicolas J, Kerdine-Römer S, Le Droumaguet B, Deloménie C, et al. 2011. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules 12:4136-43.
17. Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543-57.
18. Oberdörster G. 2010. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267:89-105.
19. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-39.
20. Parveen S, Misra R, Sahoo SK. 2012. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8: 147-66.
21. Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H. 2005. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26: 2685-94.
22. Pison U, Welte T, Giersig M, Groneberg DA. 2006. Nanomedicine for respiratory diseases. Eur J Pharmacol 533:341-50.
23. Powell MC, Kanarek MS. 2006. Nanomaterial health effects. Part 2: Uncertainties and recommendations for the future. WMJ 105:18-23.
24. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278-88.
25. Thevenot P, Cho J, Wavhal D, Timmons RE, Tang L. 2008. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine 4:226-36.
26. Val S, Hussain S, Boland S, Hamel R, Baeza-Squiban A, Marano F. 2009. Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol 21:115-22.
27. Vranic S, Boggetto N, Contremoulins V, Mornet S, Reinhardt N, Marano F, et al. 2013. Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol 10:2. doi: 10.1186/1743-8977-10-2.